Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions

다국어 초록 (Multilingual Abstract)

Purpose: This study compared the angiographic outcomes of paclitaxel-coated balloon (PCB) versus plain old balloon angioplasty(POBA) treatment for de novo coronary artery lesions. At present, there is no available data comparing the efficacy of PCB versus POBA for the treatment of de novo coronary lesions.
Materials and Methods: This multicenter retrospective observational study enrolled patients with de novo coronary lesions with a reference vessel diameter between 2.5 mm and 3.0 mm and lesion length ≤24 mm who were successfully treated with PCB or POBA. Angiographic measurements and quantitative coronary analysis were performed before and after the procedure, and at 9 months follow-up.
Results: A total of 72 patients (49 receiving PCB and 23 receiving POBA) were enrolled in this study. Late luminal loss was-0.12±0.30 mm in the PCB group and 0.25±0.50 mm in the POBA group (p<0.001). There was a higher percentage of binary restenosis(diameter stenosis ≥50%) in POBA, compared to PCB (30.4%, n=7 vs. 4.1%, n=2, p<0.001). Target vessel revascularization was higher in the POBA group (13.0%, n=3 vs. 0%, p=0.033).
Conclusion: PCB treatment of de novo coronary lesions showed better 9-month angiographic outcomes than POBA treatment alone.

참고문헌 (Reference)

1 Pires NM, "Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries" 93 : 922-927, 2007

2 Vos NS, "Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study" 10 : 584-590, 2014

3 Liu MW, "Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia" 79 : 1374-1387, 1989

4 Mintz GS, "Remodeling and restenosis: observations from serial intravascular ultrasound studies" 2 : 316-325, 2000

5 Rensing BJ, "Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study" 17 (17): 34B-38B, 1991

6 Haude M, "Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents" 21 : 26-34, 1993

7 Brilakis ES, "Perioperative management of patients with coronary stents" 49 : 2145-2150, 2007

8 Kent KM, "Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute" 49 : 2011-2020, 1982

9 Axel DI, "Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery" 96 : 636-645, 1997

10 Kleber FX, "Local paclitaxel induces late lumen enlargement in coro-nary arteries after balloon angioplasty" 104 : 217-225, 2015

11 Agostoni P, "Is bare-metal stenting superior to balloon an-gioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials" 26 : 881-889, 2005

12 Kleber FX, "Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group" 102 : 785-797, 2013

13 Gray WA, "Drug-coated balloons for the prevention of vascular restenosis" 121 : 2672-2680, 2010

14 Waksman R, "Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial" 9 : 613-619, 2013

15 Scheller B, "Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation" 42 : 1415-1420, 2003

16 Smith SC Jr, "ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)" 47 : e1-e121, 2006

17 Smith SC Jr, "ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)" 37 : 2215-2239, 2001